Implementing a year-long, worksite-based incentive program for smoking cessation.

R E Glasgow; J F Hollis; L Pettigrew; L Foster; M J Givi; G Morrisette

doi:10.4278/0890-1171-5.3.192

Home/Archive/PubMed

PubMed · 10148668

Implementing a year-long, worksite-based incentive program for smoking cessation.

R E Glasgow·J F Hollis·L Pettigrew·L Foster·M J Givi·G Morrisette

View original source ↗Export metadata ↓

Abstract

BACKGROUND: There have been few reports of the process of implementing ongoing worksite health promotion programs. This article describes the implementation of a year-long smoking cessation program in nine worksites employing a total of approximately 700 smokers. METHODS: Issues discussed include: forming a partnership with organizations, design of the multicomponent incentive intervention, program promotion, maintaining participation, and the need to modify program components over time. RESULTS: The program produced high participation rates (29% of smokers joined the program) and moderate cessation rates among participants (during the last half of the program, monthly cessation rates averaged 20%). There was marked variability across worksites on both participation and cessation, and qualitative features of organizations associated with outcome are discussed. DISCUSSION: The importance of working with employee steering committees to tailor health promotion programs to fit the organization is discussed. The article concludes with recommendations for implementation of similar programs.

Explore related subjects

Follow-Up Studies Health Promotion Humans Motivation Occupational Health Occupational Health Services Oregon Organizational Culture Outcome Assessment, Health Care Program Development Program Evaluation Smoking Cessation Clinical Trial Comparative Study Journal Article Multicenter Study Research Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

R E Glasgow, J F Hollis, L Pettigrew, L Foster, M J Givi, G Morrisette. Implementing a year-long, worksite-based incentive program for smoking cessation.. https://doi.org/10.4278/0890-1171-5.3.192

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Patent foramen ovale and cryptogenic stroke: the controversy continues.

Explore the source record for details and available documents.

Follow-Up Studies↗

PubMed2003

Spinal cord involvement in pygopagus conjoined twins: case report and review of the literature.

INTRODUCTION: Pygopagus conjoined twins are joined at the rump and have union of the gastrointestinal and genitourinary systems as well occasional involvement of neural elements. CASE REPORT: We report a case where the terminal spinal cords were fused, despite which there was only a minor motor deficit in the lower limbs after separation. The pre-operative and intra-operative findings are described and issues of long-term follow-up discussed. DISCUSSION: Seven other cases reported in the literature with varying degrees of involvement of the spinal cord and cauda equina are reviewed.

Follow-Up Studies↗

PubMed2003

Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol [ISRCTN33042138].

BACKGROUND: We have recently reported successful treatment of patients with chronic pain syndromes using human pooled intravenous immunoglobulin (IVIG) in a prospective, open-label cohort study. A randomised, placebo controlled, double blinded study is needed to confirm these results. We chose to study patients with carbamazepine resistant primary Trigeminal Neuralgia (rpTN), as these had responded particularly well to IVIG.A protocol involving the use of IVIG in rpTN is complex for three reasons: 1. The effect of IVIG does not follow simple dose-response rules; 2. The response pattern of patients to IVIG was variable and ranged between no effect at all and pain free remission between two weeks and >1 year; 3. TN is characterized by extremely severe pain, for which operative intervention is (if temporarily) helpful in most patients. DESIGN: A placebo controlled, parallel, add-on model was developed and the primary outcome variable defined as the length of time during which patients remain in the study. Study groups are compared using Kaplan-Maier survival analysis. Patients record their response to treatment ("severe, moderate, slight, no pain"). The study coordinator monitors pain diaries. Severe or moderate pain of three days duration will result in termination of the study for that patient. CONCLUSIONS: This study design utilizes a method of survival analysis and is novel in chronic pain research. It allows for both early departure from the study and voluntary crossover upon non-response. It may be applicable to the analysis of IVIG efficacy in other chronic pain syndromes.

Follow-Up Studies↗